Background: Drugs are one of most important causes of liver injury in pediatrics but so far the incidence rate of drug-related liver injury has only been estimated in the general population. Objectives: To estimate the incidence rate of liver injury in children and to identify the drugs that are associated with liver injury. Methods: A retrospective population-based cohort study was performed between 1 January 2001 and 31 December 2008 using three general practice databases in two European countries: in the Netherlands, the Integrated Primary Care Information (IPCI) database, and in Italy, Pedianet (covering children up to 14), and Health Search/Thales (HSD) (covering children from 14 years). Potential cases of liver injury were identified through codes, free text and lab values search. All potential cases were manually validated using specific algorithms by two assessors, blinded to drug exposure. Crude incidence rates (IR; 95% CI) of liver injury by country and age and gender-adjusted relative risks (RR; 95% CI) were estimated using Jerboa (http:// www.euadr-project.org/). Results: In the study cohort of 319,755 subjects aged 1-18 years, contributing 1,149,066.72 person-years (PY) of follow- up, we identified 871 new definite cases of liver injury (46 cases in IPCI, 825 cases in HSD and Pedianet). The incidence rate for liver injury was 92.6 (95% CI 86.5–99.2) per 100,000 PY in Italy and 17.9 (13.3–23.6) per 100,000 PY in the Netherlands. Pooled data showed a statistically significant age and gender adjusted increased risk of liver injury for antibacterials (RR 13.4; 95% CI 10.9–16.4), followed by corticosteroids for systemic use (11.7; 6.3–21.9), drugs for functional gastrointestinal disorders (9.7; 3.6–26.1), NSAIDs (7.6; 4.0–14.8), agents for acid related disorders (6.4; 2.7–15.5), antiepileptics (5.5; 3.2–9.5) and drugs for obstructive airway diseases (2.6; 1.7–4.1). Conclusions: The incidence of liver injury is rare in the pediatric population and heterogeneous between the two European countries. Corticosteroids, antibacterials, NSAIDs, antiepileptics and drugs for obstructive airway diseases are associated with an increased risk of liver injury.
Ferrajolo, C., Verhamme, K., Capuano, A., Trifiro, G., Oteri, A., Picelli, G., et al. (2011). Incidence Rate of Liver Injury in Pediatric Population: Data Mining on Electronic Healthcare Databases in Europe. Intervento presentato a: International Conference on Pharmacoepidemiology & Therapeutic Risk Management, Chicago, Illinois, USA.
Incidence Rate of Liver Injury in Pediatric Population: Data Mining on Electronic Healthcare Databases in Europe
Mazzaglia, G;
2011
Abstract
Background: Drugs are one of most important causes of liver injury in pediatrics but so far the incidence rate of drug-related liver injury has only been estimated in the general population. Objectives: To estimate the incidence rate of liver injury in children and to identify the drugs that are associated with liver injury. Methods: A retrospective population-based cohort study was performed between 1 January 2001 and 31 December 2008 using three general practice databases in two European countries: in the Netherlands, the Integrated Primary Care Information (IPCI) database, and in Italy, Pedianet (covering children up to 14), and Health Search/Thales (HSD) (covering children from 14 years). Potential cases of liver injury were identified through codes, free text and lab values search. All potential cases were manually validated using specific algorithms by two assessors, blinded to drug exposure. Crude incidence rates (IR; 95% CI) of liver injury by country and age and gender-adjusted relative risks (RR; 95% CI) were estimated using Jerboa (http:// www.euadr-project.org/). Results: In the study cohort of 319,755 subjects aged 1-18 years, contributing 1,149,066.72 person-years (PY) of follow- up, we identified 871 new definite cases of liver injury (46 cases in IPCI, 825 cases in HSD and Pedianet). The incidence rate for liver injury was 92.6 (95% CI 86.5–99.2) per 100,000 PY in Italy and 17.9 (13.3–23.6) per 100,000 PY in the Netherlands. Pooled data showed a statistically significant age and gender adjusted increased risk of liver injury for antibacterials (RR 13.4; 95% CI 10.9–16.4), followed by corticosteroids for systemic use (11.7; 6.3–21.9), drugs for functional gastrointestinal disorders (9.7; 3.6–26.1), NSAIDs (7.6; 4.0–14.8), agents for acid related disorders (6.4; 2.7–15.5), antiepileptics (5.5; 3.2–9.5) and drugs for obstructive airway diseases (2.6; 1.7–4.1). Conclusions: The incidence of liver injury is rare in the pediatric population and heterogeneous between the two European countries. Corticosteroids, antibacterials, NSAIDs, antiepileptics and drugs for obstructive airway diseases are associated with an increased risk of liver injury.File | Dimensione | Formato | |
---|---|---|---|
ICPE 2011.pdf
Solo gestori archivio
Dimensione
3.1 MB
Formato
Adobe PDF
|
3.1 MB | Adobe PDF | Visualizza/Apri Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.